Crystal Rock Capital Management Boston Scientific Corp Transaction History
Crystal Rock Capital Management
- $144 Million
- Q1 2025
A detailed history of Crystal Rock Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Crystal Rock Capital Management holds 69,320 shares of BSX stock, worth $7.22 Million. This represents 4.86% of its overall portfolio holdings.
Number of Shares
69,320
Previous 85,100
18.54%
Holding current value
$7.22 Million
Previous $7.6 Million
8.0%
% of portfolio
4.86%
Previous 4.89%
Shares
13 transactions
Others Institutions Holding BSX
# of Institutions
1,832Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$14 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.71 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.8 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.46 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $149B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...